KI:KO displayed a synergistic effect of impaired ErbB2 and ERRα signaling on DCM development (Fig. 1e–i), not associated with greater vascular defects, cardiomyocyte apoptosis or hypertrophy (Supplementary Fig. 1b–e). Here, ESRRA is linked to familial dilated cardiomyopathy.